195
Views
21
CrossRef citations to date
0
Altmetric
Review

Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema

&
Pages 189-197 | Published online: 09 Jan 2014

References

  • Writing Committee for the Diabetic Retinopathy Clinical Research Network. Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch. Ophthalmol.125, 469–480 (2007).
  • Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch. Ophthalmol.103, 1796–1806 (1985).
  • The Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study report no. 3. Int. Ophthalmol. Clin.27, 254–264 (1987).
  • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology98, S766–S785 (1991).
  • Striph GG, Hart WM Jr, Olk RJ. Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visual field. Ophthalmology95, 1673–1679 (1988).
  • Hudson C, Flanagan JG, Turner GS et al. Influence of laser photocoagulation for clinically significant diabetic macular edema (DMO) on short-wavelength and conventional automated perimetry. Diabetologia41, 1283–1292 (1998).
  • Sinclair SH, Alaniz R, Presti P. Laser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing. Sem. Ophthalmol.4, 214–222 (1999).
  • Schatz H, Madeira D, McDonald HR et al. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch. Ophthalmol.109, 1549–1551 (1991).
  • Lewis H, Schachat AP, Haimann MH et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology97, 503–510 (1990).
  • Guyer DR, D’Amico DJ, Smith CW. Subretinal fibrosis after laser photocoagulation for diabetic macular edema. Am. J. Ophthalmol.113, 652–656 (1992).
  • Han DP, Mieler WF, Burton TC. Submacular fibrosis after photocoagulation for diabetic macular edema. Am. J. Ophthalmol.113, 513–521 (1992).
  • Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology104(12), 2030–2038 (1997).
  • Moorman CM, Hamilton AMP. Clinical applications of the MicroPulse diode laser. Eye13(Pt 2), 145–150 (1999).
  • Stanga PE, Reck AC, Hamilton AMP. Micropulse laser in the treatment of diabetic macular edema. Semin. Ophthalmol.14(4), 210–213 (1999).
  • Friberg TR. Infrared micropulsed laser treatment for diabetic macular edema – subthreshold versus threshold lesions. Semin. Ophthalmol.16(1), 19–24 (2001).
  • Olk RJ, Akduman L. Minimal intensity diode laser photocoagulation (MIP) for diffuse DME. Semin. Ophthalmol.16(1), 25–30 (2001).
  • Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br. J. Ophthalmol.88(9), 1173–1179 (2004).
  • Tseng Shih-Yu. Clinical application of micropulse diode laser in the treatment of macular edema. Am. J. Ophthalmol.139(4), S58 (2005).
  • Bhagat N, Zarbin MA. Use of diode subthreshold micropulse laser for treating diabetic macular edema. Contemp. Ophthalmol.3(13), 1–10 (2004).
  • Bhagat N, Zarbin MA. Diode subthreshold micropulse laser for diabetic macular edema. Retinal Physician3(2), 53–56 (2006).
  • Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br. J. Ophthalmol.89(1), 74–80 (2005).
  • Luttrull JK. Atraumatic photocoagulation for retinovascular disease. Retinal Physician3(2), 65–69 (2006).
  • Luttrull JK, Spink CJ. Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg. Lasers Imaging37(5), 370–377 (2006).
  • Dare A, Castro L, Lavinsky D, Navajas E, Cardillo JA. Novos horizontes no tratamento do edema de macula diabetico: fotocoagulacao macular seletiva com micropulse de diodo 810 nm. JBO13, 16–20 (2007).
  • Sivaprasad S, Sandhu R, Tandon A, Sayed-Ahmed K, McHugh DA. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up. Clin. Experiment. Ophthalmol.35(7), 640–644 (2007).
  • Fletcher E, Chong V. Diabetic macular oedema – is micropulse laser treatment the way forward? Ophthalmol. Int.3(1), 19–22 (2008).
  • Nakamura Y, Tatsumi T, Arai M, Takatsuna Y, Mitamura Y, Yamamoto S. [Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates]. Nippon Ganka Gakkai Zasshi113(8), 787–791 (2009).
  • Figueira J, Khan J, Nunes S et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br. J. Ophthalmol.93(10), 1341–1344 (2009).
  • Ohkoshi K, Yamaguchi T. Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients. Am. J. Ophthalmol.149(1), 133–139 (2010).
  • Nakamura Y, Mitamura Y, Ogata K, Arai M, Takatsuna Y, Yamamoto S. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema. Eye (Lond.)24(5), 784–788 (2010).
  • Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina30(6), 908–916 (2010).
  • Kumar V, Ghosh B, Mehta DK, Goel N. Functional outcome of subthreshold versus threshold diode laser photocoagulation in diabetic macular oedema. Eye (Lond.)24(9), 1459–1465 (2010).
  • Lavinsky D, Cardillo JA, Melo LA Jr, Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest. Ophthalmol. Vis. Sci.52, 4314–4323 (2011).
  • Venkatesh P, Ramanjulu R, Azad R, Vohra R, Garg S. Subthreshold micropulse diode laser anddouble frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed. Laser Surg.29(11), 727–733 (2011).
  • Takatsuna Y, Yamamoto S, Nakamura Y, Tatsumi T, Arai M, Mitamura Y. Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema. Jpn J. Ophthalmol.55(4), 365–369 (2011).
  • Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Long-term safety, high-resolution imaging, and tissue temperature modeling of sub-visible diode micropulse photocoagulation for retinovascular macular edema. Retina32(2), 375–386 (2012).
  • Shah AM, Bressler NM, Jampol LM. Does laser still have a role in the management of retinal vascular and neovascular diseases? Am. J. Ophthalmol.152(3), 332–339.e1 (2011).
  • Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin. Ophthalmol.14(4), 200–209 (1999).
  • Lanzetta P, Dorin G, Piracchio A, Bandello F. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin. Ophthalmol.16(1), 8–11 (2001).
  • Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin. Ophthalmol.18(3), 147–153 (2003).
  • Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it? Semin. Ophthalmol.19(1–2), 62–68 (2004).
  • Sivaprasad S, Elagouz M, McHugh D, Shona O, Dorin G. Micropulsed diode laser therapy: evolution and clinical applications. Surv. Ophthalmol.55, 516–530 (2010).
  • Wilson AS, Hobbs BG, Shen WY et al. Argon laser photocoagulation-induced modification of gene expression in the retina. Invest. Ophthalmol. Vis. Sci.44, 1426–1434 (2003).
  • Faxel C, Bradle J, Acott T, Samples JR. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina27, 629–634 (2007).
  • Battaglia Parodi M, Spasse S, Iacono P et al. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology113, 2237–2242 (2006).
  • Parodi MB, Iacono P, Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular edema in branch retinal vein occlusion: a pilot study. Br. J. Ophthalmol.92, 1046–1050 (2008).
  • Ricci F, Missiroli F, Cerulli L. Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy. Eur. J. Ophthalmol.14(1), 74–82 (2004).
  • Lanzetta P, Furlan F, Morgante L, Verritti D, Bandello F. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur. J. Ophthalmol.18(6), 934–940 (2008).
  • Chen SN, Hwang JF, Tseng LF, Lin CJ. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology115(12), 2229–2234 (2008).
  • Ricci F, Missiroli F, Regine F, Grossi M, Dorin G. Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch. Clin. Exp. Ophthalmol.247(5), 597–607 (2009).
  • Luttrull JK, Musch DC, Spink CA. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye (Lond.)22, 607–612 (2008).
  • Kumar V, Ghosh B, Raina UK, Goel N. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy, Eye (Lond.)23(11), 2122–2123 (2009).
  • Luttrull JK, Musch DC, Spink CA. Reply to Dr Kumar et al.Eye (Lond.)23(11), 2123 (2009).
  • JA Cardillo. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Presented at: Annual Meeting of the Retina Society. Scottsdale, AZ, USA, 25–28 September, 2008
  • Mitchell P, Bandello F, Schmidt-Erfurth U et al. The RESTORE study. Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology118, 615–625 (2011).
  • Massin P, Bandello F, Garweg JG et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study). A 12-month, randomized, controlled, double-masked, multicenter Phase II study. Diabetes Care33, 2399–2405 (2010).
  • Nguyen QD, Shah SM, Khwaja AA et al. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) Study. Ophthalmology117, 2146–2151 (2010).
  • Sultan MB, Zhou D, Loftus J et al. A Phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology118, 1107–1118 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.